- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03277612
Effects of C-section Delivery on Infant Brain Development
December 18, 2023 updated by: Arkansas Children's Hospital Research Institute
The study will help investigators learn more about whether different delivery modes influence infant's brain development
Study Overview
Status
Terminated
Conditions
Detailed Description
For this study, the investigators are enrolling women who are pregnant with their second child who are planning to have a planned C-section or a spontaneous vaginal birth after C-section.
The investigators will see the pregnant mom at 36 weeks pregnant and then have the mom and the baby return for a visit at 2 weeks postnatal.
Study Type
Observational
Enrollment (Actual)
9
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arkansas
-
Little Rock, Arkansas, United States, 72202
- Arkansas Children's Nutrition Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Healthy women and their unborn child
Description
Inclusion Criteria:
- Conceived without fertility treatments
- Singleton pregnancy recruited at or before 36 weeks of gestation
- Second parity with planned repeated C-section delivery or with planned spontaneous vaginal delivery after C-section.
Exclusion Criteria:
- Preexisting medical conditions
- Sexually transmitted diseases
- Medical complications developed during pregnancy
- Medical complications developed during labor and delivery
- Emergency c-section delivery
- Infants born preterm or post-term
- Infants needing mechanical ventilation, have congenital abnormalities, birth defects, intrauterine growth restriction, low Apgar score (<7), or other medical issues developed at birth or before 2 weeks of age affecting the outcome of interest as determined by the PI.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
C-Section
Infants delivered by C-section
|
Vaginal Delivery
Infants delivered by spontaneous vaginal delivery after C-section.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gut Microbiome and how it effects Brain Structure
Time Frame: up to 2 weeks
|
Evaluate the relationship between gut microbiome and brain structural in infants based on mode of delivery as determined by an MRI
|
up to 2 weeks
|
Gut Microbiome and how it effects brain function
Time Frame: up to 2 weeks
|
Evaluate the relationship between gut microbiome and brain function in infants based on mode of delivery as determined by an MRI
|
up to 2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Xiawei Ou, PhD, Arkansas Children's Nutrition Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 22, 2017
Primary Completion (Actual)
March 25, 2019
Study Completion (Actual)
March 27, 2019
Study Registration Dates
First Submitted
June 28, 2017
First Submitted That Met QC Criteria
September 7, 2017
First Posted (Actual)
September 11, 2017
Study Record Updates
Last Update Posted (Estimated)
December 20, 2023
Last Update Submitted That Met QC Criteria
December 18, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 206515
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet